+

WO2002004598A3 - Amelioration de performances de culture cellulaire - Google Patents

Amelioration de performances de culture cellulaire Download PDF

Info

Publication number
WO2002004598A3
WO2002004598A3 PCT/US2001/021864 US0121864W WO0204598A3 WO 2002004598 A3 WO2002004598 A3 WO 2002004598A3 US 0121864 W US0121864 W US 0121864W WO 0204598 A3 WO0204598 A3 WO 0204598A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitors
pyruvate dehydrogenase
improvement
cell culture
dehydrogenase kinase
Prior art date
Application number
PCT/US2001/021864
Other languages
English (en)
Other versions
WO2002004598A2 (fr
Inventor
Brian D Follstad
Original Assignee
Immunex Corp
Brian D Follstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp, Brian D Follstad filed Critical Immunex Corp
Priority to AU2001275897A priority Critical patent/AU2001275897A1/en
Publication of WO2002004598A2 publication Critical patent/WO2002004598A2/fr
Publication of WO2002004598A3 publication Critical patent/WO2002004598A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des procédés et des compositions servant à améliorer la culture in vitro de cellules animales et mettant en application des inhibiteurs de pyruvate déshydrogénase kinase. Les inhibiteurs particulièrement préférés consistent en des sels d'acide dichloroacétique, tels que dichloroacétate de sodium.
PCT/US2001/021864 2000-07-12 2001-07-10 Amelioration de performances de culture cellulaire WO2002004598A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001275897A AU2001275897A1 (en) 2000-07-12 2001-07-10 Improvement of cell culture performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21788900P 2000-07-12 2000-07-12
US60/217,889 2000-07-12

Publications (2)

Publication Number Publication Date
WO2002004598A2 WO2002004598A2 (fr) 2002-01-17
WO2002004598A3 true WO2002004598A3 (fr) 2002-04-04

Family

ID=22812901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021864 WO2002004598A2 (fr) 2000-07-12 2001-07-10 Amelioration de performances de culture cellulaire

Country Status (2)

Country Link
AU (1) AU2001275897A1 (fr)
WO (1) WO2002004598A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765915B2 (en) 2006-02-06 2014-07-01 Csl Behring Gmbh Modified coagulation factor VIIa with extended half-life
US10011856B2 (en) 2010-05-28 2018-07-03 Genentech, Inc. Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008527980A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
EP2032607B2 (fr) 2006-06-14 2017-02-22 CSL Behring GmbH Protéine de fusion pouvant subir un clivage protéolytique et contenant un facteur de coagulation sanguine
EP1867660A1 (fr) 2006-06-14 2007-12-19 CSL Behring GmbH Protéine de fusion qui peut être clivée protéolyticalement et qui contient un facteur de la coagulation sanguine
US7939632B2 (en) 2006-06-14 2011-05-10 Csl Behring Gmbh Proteolytically cleavable fusion proteins with high molar specific activity
JP5448839B2 (ja) 2006-12-22 2014-03-19 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー インビボで長い半減期を有する修飾された凝固因子
US8637312B2 (en) 2008-01-09 2014-01-28 Cellca Gmbh Mammalian culture media with polyamine and iron
KR101040486B1 (ko) 2008-08-25 2011-06-09 경북대학교 산학협력단 Ｐｄｋ4의 신규 용도

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEBERNITZ GREGORY R ET AL: "Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, no. 11, 1 June 2000 (2000-06-01), pages 2248 - 2257, XP001026040, ISSN: 0022-2623 *
MURRAY K ET AL: "DICHLOROACETATE INCREASES CELL AND ANTIBODY YIELDS IN BATCH CULTURES OF A HYBRIDOMA CELL LINE", BIOTECHNOLOGY AND BIOENGINEERING. INCLUDING: SYMPOSIUM BIOTECHNOLOGY IN ENERGY PRODUCTION AND CONSERVATION, JOHN WILEY & SONS. NEW YORK, US, vol. 49, no. 4, 20 February 1996 (1996-02-20), pages 377 - 382, XP001022682, ISSN: 0006-3592 *
YOUNG P R ET AL: "SECRETION OF LACTIC ACID BY PERITONEAL MACROPHAGES DURING EXTRACELLULAR PHAGOCYTOSIS THE POSSIBLE ROLE OF LOCAL HYPERACIDITY IN INFLAMMATORY DEMYELINATION", JOURNAL OF NEUROIMMUNOLOGY, vol. 15, no. 3, 1987, pages 295 - 308, XP001022668, ISSN: 0165-5728 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765915B2 (en) 2006-02-06 2014-07-01 Csl Behring Gmbh Modified coagulation factor VIIa with extended half-life
US10011856B2 (en) 2010-05-28 2018-07-03 Genentech, Inc. Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

Also Published As

Publication number Publication date
AU2001275897A1 (en) 2002-01-21
WO2002004598A2 (fr) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2482800A (en) Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
WO2007030652A3 (fr) Methodes et compositions pour cultiver des cellules souches adipeuses
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
WO2005051358A8 (fr) Composition et procede pour l'amelioration de la biodisponibilite
WO2003000863A3 (fr) Polynucleotides de defensine et methodes d'utilisation
ATE362314T1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
WO2006083924A8 (fr) 1-acylamino-2-hydroxy-3-amino-w-arylalkanes comme inhibiteurs de la renine
WO2004044158A3 (fr) Cultures de cellules souches embryonnaires humaines, et compositions et procedes de culture correspondants
TW200714294A (en) Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
AU2002227156A1 (en) Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
BRPI0506713A (pt) composições de ácido peroxicarboxìlico de cadeia média
AU2003273276A1 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
YU48803A (sh) Derivati tetrahidropiridina,njihovo dobijanje i primena kao inhibitora za proliferaciju ćelija
WO2005017098A3 (fr) Compositions et methodes utilisant un arnsi, des composes amphipathiques et des polycations
EP2422615A3 (fr) Protection de protéines krp mutantes négatives dominantes d'inhibition active du complexe cycline/cdk par krp de type sauvage
EP1458870A4 (fr) Compositions et procedes utilisant un arnsi, des composes amphipathiques et des polycations
AU2001253519A1 (en) Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
WO2002004598A3 (fr) Amelioration de performances de culture cellulaire
WO2004058323A3 (fr) Formulations pouvant etre injectees directement, offrant une meilleure cryoprotection de produits cellulaires
WO2001095717A3 (fr) Procede de cryopreservation reposant sur l'utilisation d'une composition cryoprotectrice a base de propanediol et de solution vectrice
WO2007041564A3 (fr) Composes de (s)-6-methyloxaalkyl exemestane et leurs procedes d'utilisation
TW200500348A (en) Biguanide and dihydrotriazine derivatives
CA2348836A1 (fr) Aliments du betail
AU2001255393A1 (en) Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载